Hong Kong Retail Distributors Stock News

While Vobile Group Limited ( HKG:3738 ) might not have the largest market cap around , it saw a significant share price...

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

Despite an already strong run, Desun Real Estate Investment Services Group Co., Ltd. ( HKG:2270 ) shares have been...

Vobile Group Limited ( HKG:3738 ) shareholders won't be pleased to see that the share price has had a very rough month...

CITIC Limited announced past earnings results for the nine months ended September 30, 2025, reporting sales of CNY 292.36 billion and net income of CNY 40.99 billion, both up from the previous year. This financial update highlights that CITIC achieved both higher revenue and net income year-over-year, reflecting resilient performance across its diverse businesses. To assess what’s next, we’ll explore how CITIC’s stronger revenue growth in the recent report could shift its overall investment...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

On October 28, 2025, ASMPT Limited reported a third-quarter net loss of HK$269.88 million despite sales growth, while also issuing fourth-quarter 2025 revenue guidance of US$470 million to US$530 million, exceeding market expectations. The company cited strong momentum in both its SEMI and SMT segments as key drivers for the upbeat fourth-quarter outlook, signaling potential recovery following the weaker Q3 performance. We'll now examine how ASMPT's stronger-than-expected Q4 2025 guidance,...

China Resources Building Materials Technology Holdings Limited recently reported third quarter 2025 results showing a decrease in sales to CNY 4,863.99 million and net income to CNY 24.32 million compared to the previous year, alongside the resignation of an independent non-executive director and the appointment of a new board member with extensive group experience. These developments highlight both operational challenges and evolving board dynamics that could impact the company's ongoing...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Semiconductor Manufacturing International's (HKG:981) stock is up by a considerable 58% over the past three months...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Weichai Power Co., Ltd. ( HKG:2338 ) recently posted some strong earnings, and the market responded positively. Our...

The market seemed underwhelmed by last week's earnings announcement from Human Health Holdings Limited ( HKG:1419...

Key Insights Cloud Factory Technology Holdings' significant insider ownership suggests inherent interests in company's...

Novautek Technologies Group Limited's ( HKG:519 ) healthy profit numbers didn't contain any surprises for investors. We...

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

Most readers would already be aware that Enterprise Development Holdings' (HKG:1808) stock increased significantly by...

China Healthwise Holdings Limited ( HKG:348 ) shares have continued their recent momentum with a 26% gain in the last...

As the Asian markets navigate a landscape marked by mixed performances and economic shifts, investors are closely watching for opportunities amid easing U.S.-China trade tensions and Japan's record stock market highs. In this context, identifying undervalued stocks with strong fundamentals can offer potential for capital appreciation, especially as regional economies adapt to evolving global conditions.

Insiders who bought New City Development Group Limited ( HKG:456 ) stock lover the last 12 months are probably not as...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...

Key Insights Hang Lung Group's significant private companies ownership suggests that the key decisions are influenced...

Goldman Sachs recently initiated coverage on Keymed Biosciences, highlighting the approval of its first commercial product, stapokibart, in China for atopic dermatitis and chronic rhinosinusitis, while expressing confidence in the pipeline asset CM512 for asthma and COPD. This development underscores the growing recognition of Keymed's product pipeline and the confidence major institutions are placing in the company's future prospects. We'll explore how optimism for Keymed's pipeline,...